First-of-its-kind Website for Patients and Caregivers
As major advances in cancer immunotherapy begin to alter the landscape of cancer treatment, patients facing a cancer diagnosis need to be aware of immunotherapy as a potential treatment option. On June 1, 2014, CRI launched a website designed specifically for cancer patients and caregivers interested in learning about cancer immunotherapy.
TheAnswerToCancer.org (TheA2C) seeks to engage, educate, and empower patients and their loved ones to learn more about cancer immunotherapy as a treatment option across numerous tumor types. The website provides a robust but accessible overview of the science behind cancer immunotherapy, detailed information about cancer immunotherapy clinical trials, and voices from the cancer immunotherapy community.
What Is Cancer Immunotherapy? An overview of cancer immunotherapy and the several different forms it can take, from therapeutic vaccines to checkpoint inhibitors to monoclonal antibodies and more.
Benefits of Cancer Immunotherapy. A discussion of how immunotherapy differs from conventional cancer treatments and why it may be a better choice.
Cancer-specific pages, devoted to the latest immunotherapies being developed for specific tumor types.
ImmunoCommunity. Where individuals can share their stories and connect with other patients about lifesaving immunotherapies.
Cancer Immunotherapy Clinical Trial Finder. A tool that connects patients with more than 800+ immunotherapy trials currently available.
ImmunoNews. A curated listing of the latest news and advances in cancer immunotherapy.
Links to organizations that provide support and answers for cancer patients and their loved ones.
to learn more.
CRI's new website that seeks to engage, educate, and empower patients and their loved ones to learn more about cancer immunotherapy as a treatment option across numerous tumor types. - See more at: http://www.cancerresearch.org/cancer-immunotherapy#sthash.iZXxJgjw.dpuf